Despite the well-known fact that expression of p53 mutants correlates strongly to poor prognosis in cancer patients, the exact roles in the promotion of cancer progression played by p53 mutants, which vary in type as well as position, remain as yet unclear. This evidence concerns the gene TP53 and cancer.